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Previews
aspect that all three epilepsy-associated mutations pro-Sodium Channel Gating:
duced similar gating defects, several other features ofNo Margin for Error this study are noteworthy in comparison to prior efforts
at defining functional consequences of GEFS muta-
tions: a mammalian expression system was used (HEK
cells), the accessory 1 and 2 subunits were coex-Voltage-gated Na channels are the workhorses of
pressed, and most importantly the mutants were studiedspike generation and propagation in excitable cells.
in the human SCN1A cDNA (which previously had neverMutations in Na channel genes have been identified
been assembled for expression studies).in disorders causing episodic dysfunction of heart,
Is the subtle gating defect in mutant SCN1A channelsskeletal muscle, and brain. Lossin and colleagues from
a plausible cause of seizures in GEFS? The weight ofAl George’s lab report in this issue of Neuron that three
evidence is an overwhelming yes. First, the expressionmissense mutations of SCN1A found in a dominant
pattern is compatible, both temporally and spatiallyepilepsy syndrome disrupt inactivation, thereby pro-
(Goldin, 2001). Seizures in GEFS begin in childhood.ducing small persistent inward Na currents that may
SCN1A is expressed at birth, and continues into adult-result in hyperexcitability and seizures.
hood. Moreover, SCN1A is expressed widely in the CNS,
including the hippocampus and cerebral cortex, brainInherited defects of ion channels have become an ever-
regions known to be important in epileptogenesis. Sec-growing list of mutations found in monogenic disorders
ond, disruption of inactivation is now recognized as aof excitability or epithelial transport in man (Lehmann-
pathomechanism in common with mutations in otherHorn and Jurkat-Rott, 1999). Voltage-gated Na chan-
Na channel genes (SCN2A and SCN1B) that cause
nels are no exception. Na channels are heteromeric
GEFS (Sugawara et al., 2001; Wallace et al., 1998).
complexes of pore-forming  and accessory  subunits.
Third, transgenic mice with neuron-specific expression
Mutations in 4 of the 10 known  subunit genes and 1 of mutant SCN2A that fails to completely inactivate de-
of 3  subunit genes have been identified as the cause velop seizures (Kearney et al., 2001). Fourth, relatively
of epilepsy, periodic paralysis, muscle stiffness (myoto- subtle alterations in Na channel gating are established
nia), or cardiac arrhythmia (Table 1). For the majority of causes of other paroxysmal disorders of excitability. The
these, the mutations produce missense substitutions most extensively studied examples are the autosomal
that result in functional channels with subtle changes in dominantly inherited forms of myotonia and periodic
the voltage dependence of channel opening and closing paralysis (Cannon, 2000). Missense mutations in SCN4A,
(gating). the Na channel  subunit of skeletal muscle, cause
In this issue of Neuron, Lossin and colleagues report predominantly gain-of-function defects wherein inacti-
the functional consequences of three missense muta- vation is partially disrupted (similar to that observed by
tions in SCN1A recently identified in families with an Lossin in SCN1A mutants), or in a few cases activation
autosomal dominant epilepsy syndrome: GEFSor gen- is enhanced. The end result is that mutant channels
eralized epilepsy with febrile seizures plus (Escayg et conduct more inward Na current than wild-type ones.
al., 2000, 2001). A consistent gating defect was observed Interestingly, the aberrant inward current can either re-
for all three mutants. Fast inactivation at depolarized sult in pathologically enhanced excitability (small persis-
potentials was less complete than normal, so that after tent Na currents 1%–2% of the peak cause busts of
a 100 ms pulse to 10 mV, a persistent Na current, repetitive muscle fiber discharges producing sustained
ca. 1%–4% of the transient inward peak, was observed myotonic stiffness) whereas slightly more severe de-
compared to only 0.2% for wild-type channels. The dem- fects of inactivation (3%) induce a loss of muscle excit-
onstration of such small persistent currents is techni- ability manifest as flaccid weakness due to prolonged
cally demanding (the subtracted background currents depolarization-induced reduction in Na channel avail-
can be much larger), but Lossin et al. left no doubt, ability. In the heart, mutations in SCN5A that disrupt
as the same gating defects were evident during slow inactivation may delay repolarization of the cardiac ac-
depolarizing ramps or in unitary currents recorded from tion potential, which increases the risk of potentially
fatal tachyarrhythmias and is evident in the surface elec-excised membrane patches. In addition to the appealing
Table 1. Sodium Channel Genes Associated with Human Disease
Gene Channel Name Tissue Expression Disorder
SCN1A Nav1.1, brain I brain, peripheral nerve (somatic) generalized epilepsy with febrile seizures  (type 2)
SCN2A Nav1.2, brain II brain (axonal) generalized epilepsy with febrile seizures  (type 2)
SCN4A Nav1.4, SkM1, 1 adult skeletal muscle hyperkalemic periodic paralysis, hypokalemic
periodic paralysis, paramyotonia congenita,
SCN5A Nav1.5, SkM2, H1 heart, embryonic, or denervated skeletal long QT-3, idiopathic ventricular fibrillation (brugada
muscle syndrome)
SCN1B Nav1.1, 1 brain, peripheral nerve, skeletal muscle, generalized epilepsy with febrile seizures  (type 1)
heart
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trocardiogram as a prolongation of the QT interval (Ben- A Journey through the
nett et al., 1995). Species BarrierSodium channel loss-of-function defects are also a
cause of human disease. More disruptive mutations in
SCN1A that generate nonfunctional transcripts cause
severe myoclonic epilepsy of infancy (SMEI), a dominant The species barrier in prion infectivity is believed to
epilepsy syndrome that overlaps GEFS and presum- reside in the degree of amino acid sequence heterol-
ably results from haploinsufficiency (Claes et al., 2001). ogy between the infectious prion protein, PrPSc, of the
More subtle loss-of-function defects, resulting from re- donor and the normal PrP of the host. Peretz et al.
duced expression levels or altered voltage dependence (2002) bring new evidence that distinct PrPSc species
of gating, have also been implicated for idiopathic ven- or prion strains may have different conformations even
tricular fibrillation (SCN5A) and periodic paralysis (SCN4A). when they have identical amino acid sequence and
The paroxysmal nature of the symptoms in GEFS, that the conformation of the exogenous prion strain
or any of the other ion channelopathies for that matter, is a determinant of the species barrier in hosts that
remains to be adequately explained. Why does fever have identical PrP genotype.
lower seizure threshold in GEFS? What changes to
increase the susceptibility for seizures without fever The prion or protein-only hypothesis postulates that the
later in life? The interplay between genetic predisposi- pathogenic and infectious prions, PrPSc, are only made
tion and environmental triggering of symptoms is partic- of protein and derive from a normal prion protein iso-
ularly prominent in the ion channelopathies. Rest after form, PrPC (Prusiner, 1982; for general review, see Prusi-
exercise, stress, cold ambient temperature, or shifts in ner, 1999; Collinge, 2001; Gambetti et al., 2001). Forma-
serum potassium can all induce episodes of periodic tion of PrPSc involves a conformational switch by which
paralysis, myotonia, episodic ataxia, or arrhythmia. Fur- PrPC adopts the PrPSc conformation with PrPSc acting as
ther insight on how these events trigger paroxysmal template. A major challenge to this hypothesis has been
attacks will not only improve our understanding of the the existence of a wide variety of distinct prions, which
determinants of cellular excitability, but also identifies borrowing a term from virology, have been called prion
potential avenues for therapeutic intervention. strains. Another important issue related to the prion
strains is the mechanism of the species barrier—i.e.,
the degree of interspecies infectivity of a prion strainStephen C. Cannon
(Pattison, 1966). The existence of multiple prion strainsDepartment of Neurobiology
is easily explained, as are the strains of other infectiousHarvard Medical School
agents such as viruses and bacteria, by postulating theDepartment of Neurology
presence of nucleic acid in them. To fit the prion hypoth-Massachusetts General Hospital
esis, PrPSc must contain all the information to supportWellman 423/Massachusetts General Hospital
prion strain diversity and to negotiate the species bar-Boston, Massachusetts 02114
rier. The article by Peretz et al. (2002) in this issue of
Neuron addresses these issues using a new approach.Selected Reading
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